Shires Courtney Brooke, Beckmann Nic, Klug Theodore, Boughter John D
West Cancer Center, Germantown, TN, USA.
Colorado ENT & Allergy, Colorado Springs, CO, USA.
Gland Surg. 2021 Apr;10(4):1339-1346. doi: 10.21037/gs-20-441.
Compressive symptoms are common in thyroid disease. Many studies have focused on the size of the gland and its effects on patients. However, few have taken into account the body mass of the patient. The aim of our study was to examine whether or not a patient's body mass index (BMI) influences symptomatic outcomes following thyroid surgery for benign disease.
We conducted a prospective analysis evaluating 60 patients that underwent thyroidectomy for benign goiter (single or multinodular) disease. Patients were classified as obese, overweight, or normal based on BMI. Pre- and post-operative surveys were administered including the MRC breathlessness scale, M.D. Anderson Dysphagia Inventory (MDADI), and the ThyPRO quality of life questionnaire to evaluate dysphagia, dyspnea, and quality of life respectively.
Patients classified as obese (n=37) scored significantly worse pre-operatively on MRC, MDADI, and ThyPRO surveys when compared to overweight (n=13) or normal weight (n=10) counterparts. Subjects in the obese group, but not the other groups, showed post-surgical improvement on both the MRC and MDADI surveys (P<0.0001). Similarly, obese subjects showed significant improvement on all 11 domains of the ThyPRO survey following surgery (P<0.0001), and overall degree of improvement was highly correlated with BMI among all subjects (r=0.60; P=0.0005).
Obesity, as determined by BMI, is a critical factor to consider in the alleviation of compressive symptoms before and after thyroidectomy for goiter. Our analysis of survey data indicates obese subjects have increased benefit of surgery compared to their lighter counterparts.
压迫症状在甲状腺疾病中很常见。许多研究聚焦于甲状腺的大小及其对患者的影响。然而,很少有研究考虑患者的体重。我们研究的目的是检验患者的体重指数(BMI)是否会影响良性疾病甲状腺手术后的症状转归。
我们进行了一项前瞻性分析,评估了60例因良性甲状腺肿(单发或多发结节)疾病接受甲状腺切除术的患者。根据BMI将患者分为肥胖、超重或正常。术前和术后进行了调查,包括医学研究委员会(MRC)呼吸困难量表、MD安德森吞咽困难量表(MDADI)以及甲状腺PRO生活质量问卷,分别用于评估吞咽困难、呼吸困难和生活质量。
与超重(n = 13)或正常体重(n = 10)的患者相比,被归类为肥胖(n = 37)的患者在术前MRC、MDADI和甲状腺PRO调查中的得分明显更差。肥胖组的受试者,但其他组没有,在MRC和MDADI调查中术后显示出改善(P < 0.0001)。同样,肥胖受试者在术后甲状腺PRO调查的所有11个领域都显示出显著改善(P < 0.0001),并且所有受试者中总体改善程度与BMI高度相关(r = 0.60;P = 0.0005)。
由BMI确定的肥胖是甲状腺肿甲状腺切除术前和术后缓解压迫症状时需要考虑的关键因素。我们对调查数据的分析表明,与体重较轻的患者相比,肥胖受试者手术获益增加。